Wellgistics Health, Inc.
WGRXNasdaq
$2.65
↓ -0.4%Jul 17 close · end-of-day
Price
1Y↓ -93.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$277.2M
Enterprise Value
$305.0M
P/E
—
P/S
19.8
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$14.0M
Net Income (TTM)
-$76.6M
Free Cash Flow (TTM)
—
Gross Margin
-49.5%
Operating Margin
-487.5%
Net Margin
-545.7%
ROE
508.5%
ROIC
-427.0%
Debt / Equity
-1.8
Net Cash
-$27.7M
Return 1Y
-94.2%
Company profile
Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. The mailing address of our principal executive office is 3000 Bayport Drive, Suite 950 Tampa, FL.
- CEO
- Tim Canning
- Sector
- Wholesale Trade
- Industry
- Wholesale
- Employees
- 31
- Headquarters
- Florida
- Website
- www.wellgisticshealth.com/
Earnings
WGRX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.6M↓ -85.6%
Diluted EPS-$0.07↓ -88.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | — | $18.1M | $23.3M |
| Gross profit | — | $1.8M | -$6.4M |
| Operating income | -$2.9M | -$6.1M | -$93.7M |
| Net income | -$2.9M | -$6.9M | -$101.3M |
| Diluted EPS | -$0.06 | -$0.15 | -$1.43 |
| Operating cash flow | -$349,136.00 | -$1.2M | -$10.9M |
| Free cash flow | — | — | — |
| Gross margin | — | 9.7% | -27.5% |
| Operating margin | — | -33.9% | -401.7% |
| Net margin | — | -37.8% | -433.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44,540.00 | $5.7M | — | $10.9M | $7.8M | $3.0M | $1.7M | $1.6M |
| Gross profit | -$2,608.00 | $521,244.00 | — | $692,641.00 | $505,752.00 | $231,012.00 | -$7.9M | $170,221.00 |
| Operating income | -$573,016.00 | -$1.7M | -$3.7M | -$31.3M | -$5.5M | -$31.5M | -$25.4M | -$6.0M |
| Net income | -$574,325.00 | -$1.9M | -$4.3M | -$32.4M | -$6.7M | -$34.3M | -$27.9M | -$7.7M |
| Diluted EPS | -$0.01 | -$0.04 | -$0.10 | -$0.62 | -$0.11 | -$0.46 | -$0.24 | -$0.07 |
| Operating cash flow | $329,956.00 | $1.0M | -$2.6M | -$1.3M | -$2.1M | -$1.1M | -$6.3M | -$3.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | -5.9% | 9.2% | — | 6.4% | 6.5% | 7.7% | -470.2% | 10.9% |
| Operating margin | -1286.5% | -30.8% | — | -288.6% | -70.6% | -1047.1% | -1517.5% | -385.7% |
| Net margin | -1289.5% | -32.9% | — | -298.5% | -85.6% | -1139.0% | -1667.2% | -496.5% |
Company news
Jul 16, 2026
Jul 15, 2026
Jun 30, 2026
Jun 26, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-22 | AJJARAPU SURENDRA K | X | 100,000 | $0.01 | $500.00 | filing |
| 2026-06-22 | Patel Prashant· Chief Executive Officer | X | 100,000 | $0.01 | $500.00 | filing |
| 2026-03-31 | Patel Prashant· Chief Executive Officer | Award | 5,000,000 | $0.20 | $1.0M | filing |
| 2026-03-31 | AJJARAPU SURENDRA K | Award | 5,000,000 | $0.20 | $1.0M | filing |
| 2026-03-31 | Patel Prashant· Chief Executive Officer | Award | 5,000,000 | $0.20 | $1.0M | filing |
| 2026-03-31 | AJJARAPU SURENDRA K | Award | 5,000,000 | $0.20 | $1.0M | filing |
| 2025-07-02 | PETERSON MICHAEL L | Award | 200,000 | $0.90 | $180,000.00 | filing |
Latest 7 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.